Viagra Research Today is a free monthly online journal that collates and summarizes the latest research about Viagra, including details on sildenafil, erectile dysfunction, impotence, side-effects, alternatives.

Volume 2 (2005), Issue 4 (April)

1. Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity.
   Circulation, 111(13): 1601-10. [Abstract] [Full-text]
2. Inhibition of cGMP-specific phosphodiesterase type 5 reduces sodium excretion and arterial blood pressure in patients with NaCl retention and ascites.
   Am J Physiol Renal Physiol, 288(5): F1044-52. [Abstract] [Full-text]
3. Safety and efficacy of Sildenafil therapy in children with pulmonary hypertension.
   Int J Cardiol, 100(2): 267-73. [Abstract] [Full-text]
4. A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis.
   J Neurol Neurosurg Psychiatry, 76(5): 700-5. [Abstract] [Full-text]
5. Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response.
   Urology, 65(4): 755-9. [Abstract] [Full-text]
6. Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED.
   Bioorg Med Chem Lett, 15(9): 2365-9. [Abstract] [Full-text]
7. Analysis of the mechanism underlying the peripheral antinociceptive action of sildenafil in the formalin test.
   Eur J Pharmacol, 512(2): 121-7. [Abstract] [Full-text]
8. Sildenafil for pulmonary hypertension.
   Ann Pharmacother, 39(5): 869-84. [Abstract] [Full-text]
9. Structural chemoproteomics and drug discovery.
   Biopolymers, 80(2): 258-63. [Abstract] [Full-text]
10. Iloprost for idiopathic pulmonary arterial hypertension.
    Expert Rev Cardiovasc Ther, 3(2): 215-23. [Abstract] [Full-text]

© 2004-2008 Viagra Research Today. All Rights Reserved.